Sign Up to like & get
recommendations!
0
Published in 2021 at "BMC Nephrology"
DOI: 10.1186/s12882-021-02386-y
Abstract: Background Gemcitabine and cisplatin are chemotherapeutic agents used for treating multiple cancers, and these agents are sometimes used in combination. Drug-induced thrombotic microangiopathy (TMA) is a rare but potentially fatal complication. It typically presents as…
read more here.
Keywords:
gemcitabine dexamethasone;
cisplatin therapy;
cisplatin;
dexamethasone cisplatin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Acta medica Okayama"
DOI: 10.18926/amo/57379
Abstract: Romidepsin is an important therapeutic option for patients with peripheral T-cell lymphoma (PTCL). However, the timing of romidepsin administration remains controversial. Romidepsin was launched in Japan as a consolidation therapy agent after conventional salvage chemotherapy…
read more here.
Keywords:
therapy;
gemcitabine dexamethasone;
cell lymphoma;
peripheral cell ... See more keywords